Convolvulus Scammonia

Convolvulus scammonia  Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Convolvulaceae.
Habitat A native to the Mediterranean region.
English Scammony.
Unani Saqmunia.
Action Resin from rhizomes—hydragogue, Cathartic, administered in dropsy and anascara.
Taxonomic Cohort Genus Convolvulus (3 documented species); Family Convolvulaceae (35 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Convolvulus scammonia (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Convolvulaceae (primary family classification: Convolvulaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: A native to the Mediterranean region.

Across classical and vernacular Indian systems of medicine, Convolvulus scammonia is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Scammony; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Saqmunia. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Convolvulus scammonia are: Resin from rhizomes—hydragogue, Cathartic, administered in dropsy and anascara. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Convolvulus scammonia establish the following evidence base: Most of the resin available in India is imported from Syria and Asia Minor and is grossly adulterated. The roots contain on an average 8% resin together with dihydroxy cinnamic acid, beta-methyl-esculetin, ipuranol, surcose, a reducing sugar and starch. The resin consists of the glycosides and methylpentosides of jalapinolic acid and its methyl ester. Large doses cause acute gastro-intestinal irritation, and, if absorbed, produce cystitis and nephritis.

image2

Botanical Reference 1: Convolvulus scammonia — Botanical specimen

image3

Botanical Reference 2: Convolvulus scammonia — Botanical specimen

image3

Botanical Reference 3: Convolvulus scammonia — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Convolvulus comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Convolvulus arvensis (Action: Plant—cooling, anticonvulsant. Root—cathartic); Convolvulus pluricaulis (Action: Plant—brain tonic, tranquilizer used in nervine disorders, mental aberration…). Comparing Convolvulus scammonia alongside its congeners in genus Convolvulus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Convolvulaceae encompasses 35 documented medicinal species (1.93% of the 1,814-species flora). Other representative medicinal members of Convolvulaceae include: Argyreia speciosa (Vriddhadaaruka), Convolvulus arvensis (Bhadrabalaa), Convolvulus pluricaulis (Shankhapushpi), Cressa cretica (Rudanti), Cuscuta epithymum (Aakaashvalli). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 35 medicinal species of family Convolvulaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Convolvulus scammonia follow the plant-part modalities specified under its therapeutic action (Resin from rhizomes—hydragogue, Cathartic, administered in dropsy and anascara), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Convolvulus scammonia integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top